Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 2Gynecologic 1

Conditions

Anemia, Iron-Deficiency 2Anemia 1Anaemia in Ovarian Carcinoma 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × ferric derisomaltose × Clear all
NCT05407987 2025-04-25

FORGE II

AHS Cancer Control Alberta

Phase 3 Recruiting
82 enrolled
Classical hematology

Anemia, Anemia, Iron-Deficiency

NCT06248749 2024-02-08

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

University of Saskatchewan

Phase 3 Not yet recruiting
200 enrolled
Gynecologic

Anaemia in Ovarian Carcinoma

NCT05467319 2022-07-20

FORGE

Alberta Health Services, Calgary

Phase 3 Unknown
82 enrolled
Classical hematology

Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡